Literature DB >> 19667193

Ultraslow oligomerization equilibria of p53 and its implications.

Eviatar Natan1, Daniel Hirschberg, Nina Morgner, Carol V Robinson, Alan R Fersht.   

Abstract

The tumor suppressor p53 is in equilibrium at cellular concentrations between dimers and tetramers. Oncogenic mutant p53 (mut) exerts a dominant-negative effect on co-expression of p53 wild-type (wt) and mut alleles in cancer cells. It is believed that wt and mut form hetero-tetramers of attenuated activity, via their tetramerization domains. Using electrospray mass spectrometry on isotopically labeled samples, we measured directly the composition and rates of formation of p53 complexes in the presence and absence of response element DNA. The dissociation of tetramers was unexpectedly very slow (t(1/2) = 40 min) at 37 degrees C, matched by slow association of dimers, which is approximately four times longer than the half-life of spontaneous denaturation of wt p53. On mixing wt tetramers with the oncogenic contact mutant R273H of low DNA affinity, we observed the same slow formation of only wt(4), wt(2)mut(2), and mut(4), in the ratio 1:2:1, on a cellular time scale. On mixing wt and mut with response element DNAs P21 and BAX, we observed only the complexes wt(4)xDNA, wt(2)mut(2)xDNA, and mut(4)xDNA, with relative dissociation constants 1:4:71 and 1:13:85, respectively, accounting for the dominant-negative effect by weakened affinity. p53 dimers assemble rapidly to tetramers on binding to response element DNA, initiated by the p53 DNA binding domains. The slow oligomerization of free p53, competing with spontaneous denaturation, has implications for the possible regulation of p53 by binding proteins and DNA that affect tetramerization kinetics as well as equilibria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667193      PMCID: PMC2731847          DOI: 10.1073/pnas.0907840106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Kinetic instability of p53 core domain mutants: implications for rescue by small molecules.

Authors:  Assaf Friedler; Dmitry B Veprintsev; Lars O Hansson; Alan R Fersht
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

2.  Quantitative evaluation of noncovalent chorismate mutase-inhibitor binding by ESI-MS.

Authors:  Silke Wendt; Gregor McCombie; Jürg Daniel; Alexander Kienhöfer; Donald Hilvert; Renato Zenobi
Journal:  J Am Soc Mass Spectrom       Date:  2003-12       Impact factor: 3.109

3.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 4.  The role of mass spectrometry in structure elucidation of dynamic protein complexes.

Authors:  Michal Sharon; Carol V Robinson
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

5.  Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Authors:  A N Bullock; J Henckel; A R Fersht
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

6.  Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.

Authors:  Andreas C Joerger; Hwee Ching Ang; Dmitry B Veprintsev; Caroline M Blair; Alan R Fersht
Journal:  J Biol Chem       Date:  2005-02-09       Impact factor: 5.157

7.  Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers.

Authors:  Lawrence R Dearth; Hua Qian; Ting Wang; Timothy E Baroni; Jue Zeng; Stephanie W Chen; Sun Young Yi; Rainer K Brachmann
Journal:  Carcinogenesis       Date:  2006-07-21       Impact factor: 4.944

8.  Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.

Authors:  M Marutani; H Tonoki; M Tada; M Takahashi; H Kashiwazaki; Y Hida; J Hamada; M Asaka; T Moriuchi
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex.

Authors:  Henning Tidow; Roberto Melero; Efstratios Mylonas; Stefan M V Freund; J Guenter Grossmann; José María Carazo; Dmitri I Svergun; Mikel Valle; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

10.  Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA.

Authors:  Dmitry B Veprintsev; Alan R Fersht
Journal:  Nucleic Acids Res       Date:  2008-01-30       Impact factor: 16.971

View more
  22 in total

1.  Polypyrimidine tract-binding protein stimulates the poliovirus IRES by modulating eIF4G binding.

Authors:  Panagiota Kafasla; Nina Morgner; Carol V Robinson; Richard J Jackson
Journal:  EMBO J       Date:  2010-09-21       Impact factor: 11.598

2.  Structural evolution of p53, p63, and p73: implication for heterotetramer formation.

Authors:  Andreas C Joerger; Sridharan Rajagopalan; Eviatar Natan; Dmitry B Veprintsev; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-07       Impact factor: 11.205

3.  Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.

Authors:  Michal Bista; Stefan M Freund; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-12       Impact factor: 11.205

4.  Escherichia coli single-stranded DNA-binding protein: nanoESI-MS studies of salt-modulated subunit exchange and DNA binding transactions.

Authors:  Claire E Mason; Slobodan Jergic; Allen T Y Lo; Yao Wang; Nicholas E Dixon; Jennifer L Beck
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

5.  Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes.

Authors:  Paola Monti; Chiara Perfumo; Alessandra Bisio; Yari Ciribilli; Paola Menichini; Debora Russo; David M Umbach; Michael A Resnick; Alberto Inga; Gilberto Fronza
Journal:  Mol Cancer Res       Date:  2011-02-22       Impact factor: 5.852

6.  Mechanism and rates of exchange of L7/L12 between ribosomes and the effects of binding EF-G.

Authors:  Stéphanie Deroo; Suk-Joon Hyung; Julien Marcoux; Yuliya Gordiyenko; Ravi Kiran Koripella; Suparna Sanyal; Carol V Robinson
Journal:  ACS Chem Biol       Date:  2012-04-18       Impact factor: 5.100

Review 7.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

8.  Monitoring the dynamics of monomer exchange using electrospray mass spectrometry: the case of the dimeric glucosamine-6-phosphate synthase.

Authors:  Guillaume Chevreux; Cédric Atmanene; Philippe Lopez; Jamal Ouazzani; Alain Van Dorsselaer; Bernard Badet; Marie-Ange Badet-Denisot; Sarah Sanglier-Cianférani
Journal:  J Am Soc Mass Spectrom       Date:  2011-01-15       Impact factor: 3.109

9.  p53 sumoylation: mechanistic insights from reconstitution studies.

Authors:  Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Epigenetics       Date:  2009-10-09       Impact factor: 4.528

10.  A single-molecule characterization of p53 search on DNA.

Authors:  Anahita Tafvizi; Fang Huang; Alan R Fersht; Leonid A Mirny; Antoine M van Oijen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.